Abstract: Various implementations include approaches and systems for isolating acellular biological therapeutics. In a particular implementation, a method includes: drawing leukocyte- and platelet-rich plasma (L-PRP) into a first syringe, passing the L-PRP from the first syringe through a syringe filter to provide filtered L-PRP, drawing the filtered L-PRP into a second syringe, the second syringe having at least one protein precipitating agent (PPA) to provide a L-PRP/PPA mixture, performing a phase separation of protein precipitate and liquid phase from the L-PRP/PPA mixture, removing the liquid phase to yield a concentrated protein precipitate, passing the concentrated protein precipitate and water through a filtering tube, the filtering tube isolating concentrated protein from the concentrated protein precipitate and water, and collecting the concentrated protein.

Abstract: Biomaterials containing viable stem cells, methods of making the biomaterials, and methods of promoting musculoskeletal tissue healing in a mammal. The stem cell-based regenerative biomaterial may include an active ingredient including umbilical cord-derived mesenchymal stem cells, isolated and expanded at low-oxygen similar to that experienced in degenerative human tissues. This preconditioning enables the injected stem cells to better adapt to the degenerative microenvironment resulting in improved viability.

Abstract: Biomaterials, implants made therefrom, methods of making the biomaterial and implants, methods of promoting bone or wound healing in a mammal by administering the biomaterial or implant to the mammal, and kits that include such biomaterials, implants, or components thereof. The biomaterials may include demineralized cortical fibers, which help to promote bone repair.

Abstract: Biomaterials, implants made therefrom, methods of making the biomaterial and implants, methods of promoting bone or wound healing in a mammal by administering the biomaterial or implant to the mammal, and kits that include such biomaterials, implants, or components thereof. The biomaterials may include demineralized cortical fibers, which help to promote bone repair.

Abstract: A method and system for determining an extent of matter removed from a targeted anatomical structure are disclosed. The method includes acquiring an initial representation of a targeted anatomical structure and then removing matter from the targeted anatomical structure. An instrument is then navigated within the targeted anatomical structure. The instrument includes a tracking array, and a relative position of the instrument within the targeted anatomical structure is determined by the tracking array. The method includes recording the relative position of the instrument within the targeted anatomical structure to determine a final representation of the targeted anatomical structure. Finally, the method includes determining an extent of matter removed from the targeted anatomical structure by comparing the initial representation of the targeted anatomical structure with the final representation of the targeted anatomical structure.

Abstract: Biomaterials, implants made therefrom, methods of making the biomaterial and implants, methods of promoting bone or wound healing in a mammal by administering the biomaterial or implant to the mammal, and kits that include such biomaterials, implants, or components thereof. The biomaterials may include demineralized cortical fibers, which help to promote bone repair.